References
Pawlik TM, Zorzi D, Abdalla EK, et al. Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol (in press)
Dimick J, Wainess R, Cowan J, Upchurch G, Knol J, Colletti L. National trends in the use and outcomes of hepatic resection. J Am Coll Surg 2004;199:31–8
Papachristou D, Fortner J. Surgical treatment of metastatic melanoma confined to the liver. Int Surg 1983;68:145–8
Fong Y. Surgical therapy of hepatic colorectal metastases. CA Cancer J Clin 1999;49:231–55
Rose D, Essner R, Hughes T, et al. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg 2001;136:950–5
Sjovall A, Jary V, Blomqvist L, et al. The potential for improved outcome in patients with hepatic metastases from colon cancer: a population-based study. Eur J Surg Oncol 2004;30:834–41
Bleicher R, Allegra D, Nora D, Wood T, Foshag L, Bilchik A. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 2003;10:52–8
Feldman E, Pingpank J, Alexander H. Regional treatment options for patients with ocular melanoma metastatic to the liver. Ann Surg Oncol 2004;11:290–7
Aoyama T, Mastrangelo M, Berd D, et al. Protracted survival after resection of metastatic uveal melanoma. Cancer 2000;89:1561–8
Hsueh E, Essner R, Foshag L, Ye X, Wang H, Morton D. Prolonged survival after complete resection of metastases from intraocular melanoma. Cancer 2004;100:122–9
Eton O, Legha S, Bedikian A, et al. Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial. J Clin Oncol 2002;20:2045–52
Morton D, Ollila D, Hsueh E, Essner R, Gupta R. Cytoreductive surgery and adjuvant immunotherapy: a new management paradigm for metastatic melanoma. CA Cancer J Clin 1999;49:101–16
Morton DL, Essner R, Balch CM. Surgical excision of distant metastases. In: Balch CM, Houghton AN, Sober AJ, Soong SJ (eds). Cutaneous Melanoma. 4th ed. St. Louis: Quality Medical Publishing, 2003:pp 547–72
Ollila D, Stern S, Morton D. Tumor doubling time: a selection factor for pulmonary resection of metastatic disease. J Surg Oncol 1998;69:206–11
Acknowledgments
Supported by grant CA76489 from the National Cancer Institute and by funding from the Nancy and Carroll O’Connor Foundation (Los Angeles, CA) and the Wayne and Gladys Valley Foundation (Oakland, CA).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Faries, M.B., Morton, D.L. The Promise of Metastasectomy in Melanoma. Ann Surg Oncol 13, 607–609 (2006). https://doi.org/10.1245/ASO.2006.01.901
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/ASO.2006.01.901